Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

REGISTER for free or LOG IN to view this content

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Clinical Pharma

Coronary

CAD Pharma

DES/BRS/DCB

Atrial Fibrillation

Heart Rhythm Pharma

Factoid

Up Next

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

More slides +

Presentation

Myocardial Damage in Patients With Deferred Stenting After STEMI

June 05, 2017

Presentation

Outcomes With Boston Scientific Lotus Valve and Edwards Lifesciences Sapien 3

June 06, 2017

Country